Search research articles
Contact Us
Filters
Showing results (301-310 of 338) with videos related to
Page
of 34
Sort By:
Cancer
|
June 8, 2012
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial
Jong-Mu Sun, Ki Hyeong Lee, Sang-We Kim, et al.
The Journal of Molecular Diagnostics : JMD
|
December 19, 2012
Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer
Maruja E Lira, Tae Min Kim, Donghui Huang, et al.
Oncotarget
|
May 7, 2017
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences
Minho Cho, Soomin Ahn, Mineui Hong, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 26, 2021
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
Jiae Koh, Sohyun Kim, Sang Nam Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
Eun Ji Lee, Ji Ae Ko, Min-Je Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer
Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 13, 2014
[Investigation on measles cases of new genotype D8 in Beijing, 2013]
Juan Li, Li Lu, Rui Ma, et al.
The Lancet. Oncology
|
December 24, 2011
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor
Yeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 338) with videos related to
Sort By:
Page
of 34
Cancer
|
June 8, 2012
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial
Jong-Mu Sun, Ki Hyeong Lee, Sang-We Kim, et al.
The Journal of Molecular Diagnostics : JMD
|
December 19, 2012
Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer
Maruja E Lira, Tae Min Kim, Donghui Huang, et al.
Oncotarget
|
May 7, 2017
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences
Minho Cho, Soomin Ahn, Mineui Hong, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 26, 2021
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
Jiae Koh, Sohyun Kim, Sang Nam Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
Eun Ji Lee, Ji Ae Ko, Min-Je Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer
Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 13, 2014
[Investigation on measles cases of new genotype D8 in Beijing, 2013]
Juan Li, Li Lu, Rui Ma, et al.
The Lancet. Oncology
|
December 24, 2011
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor
Yeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.
Page
of 34